Study details
Enrolling now
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
University of California, Irvine
NCT IDNCT07447050ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Ages
18+
Locations
1 site in CA
What this study is about
This Phase 2 study is testing Riluzole in people with breast cancer.
Simplified from trial records by PatientMatch.
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Standard assignment
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
riluzole
Drug routes
oral (Oral Tablet)
Body systems
Oncology